Literature DB >> 18160523

Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.

Radoslaw Izdebski1, Jens Rutschmann, Janusz Fiett, Ewa Sadowy, Marek Gniadkowski, Waleria Hryniewicz, Regine Hakenbeck.   

Abstract

Penicillin-binding proteins (PBPs) in representatives of two Streptococcus pneumoniae clonal groups that are prevalent in Poland, Poland 23F-16 and Poland 6B-20, were investigated by PBP profile analysis, antibody reactivity pattern analysis, and DNA sequence analysis of the transpeptidase (TP) domain-encoding regions of the pbp2x, pbp2b, and pbp1a genes. The isolates differed in their MICs of beta-lactam antibiotics. The majority of the 6B isolates were intermediately susceptible to penicillin (penicillin MICs, 0.12 to 0.5 microg/ml), whereas all 23F isolates were penicillin resistant (MICs, >or=2 microg/ml). The 6B isolates investigated had the same sequence type (ST), determined by multilocus sequence typing, as the Poland 6B-20 reference strain (ST315), but in the 23F group, isolates with three distinct single-locus variants (SLVs) in the ddl gene (ST173, ST272, and ST1506) were included. None of the isolates showed an identical PBP profile after labeling with Bocillin FL and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and only one pair of 6B isolates and one pair of 23F isolates (ST173 and ST272) each contained an identical combination of PBP 2x, PBP 2b, and PBP 1a TP domains. Some 23F isolates contained PBP 3 with an apparently higher electrophoretic mobility, and this feature also did not correlate with their STs. The data document a highly variable pool of PBP genes as a result of multiple gene transfer and recombination events within and between different clonal groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160523      PMCID: PMC2258499          DOI: 10.1128/AAC.01082-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

3.  Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; J A Brannigan; R C George; D Hansman; J Liñares; A Tomasz; J M Smith; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci.

Authors:  D Jabes; S Nachman; A Tomasz
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in beta-lactam resistance.

Authors:  Estelle Pagliero; Laurent Chesnel; Julie Hopkins; Jacques Croizé; Otto Dideberg; Thierry Vernet; Anne Marie Di Guilmi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.

Authors:  R Hakenbeck; S Tornette; N F Adkinson
Journal:  J Gen Microbiol       Date:  1987-03

8.  A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics.

Authors:  Lucile Pernot; Laurent Chesnel; Audrey Le Gouellec; Jacques Croizé; Thierry Vernet; Otto Dideberg; Andréa Dessen
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

9.  Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; N Woodford; A P Johnson; R C George; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; B G Spratt
Journal:  Mol Microbiol       Date:  1989-01       Impact factor: 3.501

View more
  11 in total

1.  Characterization of mutants deficient in the L,D-carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of Streptococcus pneumoniae serotype 2 strain D39.

Authors:  Skye M Barendt; Lok-To Sham; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2011-03-04       Impact factor: 3.490

2.  Expansion and evolution of the Streptococcus pneumoniae Spain9V-ST156 clonal complex in Poland.

Authors:  Ewa Sadowy; Alicja Kuch; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 3.  Mechanisms of genome evolution of Streptococcus.

Authors:  Cheryl P Andam; William P Hanage
Journal:  Infect Genet Evol       Date:  2014-11-13       Impact factor: 3.342

4.  Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.

Authors:  Todd A Davies; Wenping He; Karen Bush; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

5.  Molecular characteristics of penicillin-binding protein 2b, 2x and 1a sequences in Streptococcus pneumoniae isolates causing invasive diseases among children in Northeast China.

Authors:  X Zhou; J Liu; Z Zhang; Y Liu; Y Wang; Y Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-14       Impact factor: 3.267

6.  Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.

Authors:  Marisa Haenni; Laure Galofaro; Mathilde Ythier; Marlyse Giddey; Paul Majcherczyk; Philippe Moreillon; Jean-Yves Madec
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

7.  A Fluorescent Teixobactin Analogue.

Authors:  Michael A Morris; Melody Malek; Mohammad H Hashemian; Betty T Nguyen; Sylvie Manuse; Kim Lewis; James S Nowick
Journal:  ACS Chem Biol       Date:  2020-02-26       Impact factor: 5.100

8.  Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease.

Authors:  Fereshteh Fani; Philippe Leprohon; Danielle Légaré; Marc Ouellette
Journal:  Genome Biol       Date:  2011-11-22       Impact factor: 13.583

9.  Molecular characterization of serogroup 19 Streptococcus pneumoniae in the Czech Republic in the post-vaccine era.

Authors:  Helena Žemličková; Lucia Mališová; Petra Španělová; Vladislav Jakubů; Jana Kozáková; Martin Musílek; Matej Medvecký
Journal:  J Med Microbiol       Date:  2018-07       Impact factor: 2.472

10.  Serotype Distribution, Antimicrobial Susceptibility, and Multilocus Sequencing Type (MLST) of Streptococcus pneumoniae From Adults of Three Hospitals in Shanghai, China.

Authors:  Xin-Xin Li; Shu-Zhen Xiao; Fei-Fei Gu; Sheng-Yuan Zhao; Qing Xie; Zi-Ke Sheng; Yu-Xing Ni; Jie-Ming Qu; Li-Zhong Han
Journal:  Front Cell Infect Microbiol       Date:  2019-11-27       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.